Contineum Therapeutics (CTNM) Interest & Investment Income (2023 - 2024)
Historic Interest & Investment Income for Contineum Therapeutics (CTNM) over the last 2 years, with Q4 2024 value amounting to $2.5 million.
- Contineum Therapeutics' Interest & Investment Income rose 4122.91% to $2.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.9 million, marking a year-over-year increase of 9335.65%. This contributed to the annual value of $8.9 million for FY2024, which is 9333.48% up from last year.
- Latest data reveals that Contineum Therapeutics reported Interest & Investment Income of $2.5 million as of Q4 2024, which was up 4122.91% from $2.7 million recorded in Q3 2024.
- Contineum Therapeutics' 5-year Interest & Investment Income high stood at $2.7 million for Q3 2024, and its period low was $401000.0 during Q1 2023.